Spago Nanomedical AB (publ)
F:7UX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Spago Nanomedical AB (publ)
F:7UX
|
SE |
|
FBR Ltd
ASX:FBRDD
|
AU |
|
Hexagon Energy Materials Ltd
F:F93
|
AU |
|
T
|
Tredegar Corp
XBER:T70
|
US |
|
C
|
Campbell Resources Inc
OTC:CBLRF
|
CA |
|
S
|
Simpson Manufacturing Co Inc
XMUN:TWL
|
US |
|
M
|
Macpac Films Ltd
KAR:MACFL
|
PK |
|
B
|
Bright Scholar Education Holdings Ltd
F:BSK0
|
CN |
|
North Media A/S
F:3S8
|
DK |
|
Phoenix Spree Deutschland Ltd
F:A2E
|
JE |
|
Leslie's Inc
F:LE3
|
US |
|
Samco Inc
F:SMU
|
JP |
Wall St Price Targets
7UX Price Targets Summary
Spago Nanomedical AB (publ)
According to Wall Street analysts, the average 1-year price target for 7UX is 0.0217 EUR with a low forecast of 0.0214 EUR and a high forecast of 0.0223 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7UX's stock price target?
Price Target
0.0217
EUR
According to Wall Street analysts, the average 1-year price target for 7UX is 0.0217 EUR with a low forecast of 0.0214 EUR and a high forecast of 0.0223 EUR.
What is the Revenue forecast for Spago Nanomedical AB (publ)?
Projected CAGR
33%
Over the last 8 years, the compound annual growth rate for Revenue has been 32%. The projected CAGR for the next 3 years is 33%.